Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Nephrology | Infections and Infectious Diseases | Family Medicine

Interstitial Cystitis Clinical Trials

A listing of Interstitial Cystitis medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


First 1 2 Last 

Alabama

MediciNova Investigational Site
Birmingham Alabama 35294

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

California

Citrus Valley Medical Research , Inc.
Glendora California 91741
Updated

A clinical trial to evaluate treatments using LiRIS 400 mg and LiRIS Placebo for patients with Interstitial Cystitis

MediciNova Investigational Site
Glendora California 91741

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

MediciNova Investigational Site
Long Beach California 90806

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

California Stem Cell Treatment Center
Rancho Mirage California 92270

A clinical trial to evaluate treatments using Administration of autologous adipose derived SVF

MediciNova Investigational Site
San Diego California 92103

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Colorado

MediciNova Investigational Site
Boulder Colorado 80304

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

MediciNova Investigational Site
Wheat Ridge Colorado 80033

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Florida

MediciNova Investigational Site
Aventura Florida 33180

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

MediciNova Investigational Site
Boynton Beach Florida 33437

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Atlantic Urological Associates
Daytona Beach Florida 32114
Updated

A clinical trial to evaluate treatments using LiRIS 400 mg and LiRIS Placebo for patients with Interstitial Cystitis

MediciNova Investigational Site
Palm Harbor Florida 34684

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

MediciNova Investigational Site
Plantation Florida 33317

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

View More »

MediciNova Investigational Site
Wellington Florida 33414

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Georgia

MediciNova Investigational Site
Atlanta Georgia 30309

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Illinois

MediciNova Investigational Site
Centralia Illinois 62801

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

MediciNova Investigational Site
Evanston Illinois 60201

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Kansas

The UrogynecologyCenter, LLC
Overland Park Kansas 66209-2002
Updated

A clinical trial to evaluate treatments using LiRIS 400 mg and LiRIS Placebo for patients with Interstitial Cystitis

Louisiana

MediciNova Investigational Site
Shreveport Louisiana 71106

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Michigan

Female Pelvic Medicine & Urogynecology Institute of MI
Grand Rapids Michigan 49503
Updated

A clinical trial to evaluate treatments using LiRIS 400 mg and LiRIS Placebo for patients with Interstitial Cystitis

William Beaumont Hospitals
Royal Oak Michigan 48073
Updated

A clinical trial to evaluate treatments using LiRIS 400 mg and LiRIS Placebo for patients with Interstitial Cystitis

MediciNova Investigational Site
Royal Oak Michigan 48073

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Nevada

MediciNova Investigational Site
Las Vegas Nevada 89109

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

New Jersey

MediciNova Investigational Site
Marlton New Jersey 08053

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

New Mexico

New York

MediciNova Investigational Site
Albany New York 12206

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Arthur Smith Institute of Urology
New Hyde Park New York 11040
Updated

A clinical trial to evaluate treatments using LiRIS 400 mg and LiRIS Placebo for patients with Interstitial Cystitis

North Carolina

Alliance Urology Specialists, PA
Greensboro North Carolina 27403
Updated

A clinical trial to evaluate treatments using LiRIS 400 mg and LiRIS Placebo for patients with Interstitial Cystitis

MediciNova Investigational Site
Winston-Salem North Carolina 27103

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Ohio

The Urology Group
Cincinnati Ohio 45212
Updated

A clinical trial to evaluate treatments using LiRIS 400 mg and LiRIS Placebo for patients with Interstitial Cystitis

MediciNova Investigational Site
Cincinnati Ohio 45212

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

MetroHealth Medical Center
Cleveland Ohio 44109
Updated

A clinical trial to evaluate treatments using LiRIS 400 mg and LiRIS Placebo for patients with Interstitial Cystitis

MediciNova Investigational Site
Lima Ohio 45805

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Oregon

MediciNova Investigational Site
Tualatin Oregon 97062

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Pennsylvania

Pelvic and Sexual Health Institute
Philadelphia Pennsylvania 19107

Patients are needed to participate in a clinical research study of Interstim to evaluate Interstitial Cystitis

South Carolina

MediciNova Investigational Site
Greer South Carolina 29650

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Carolina Urologic Research Center
Myrtle Beach South Carolina 29572
Updated

A clinical trial to evaluate treatments using LiRIS 400 mg and LiRIS Placebo for patients with Interstitial Cystitis

Tennessee

Volunteer Research Group, University of Tennessee Medical Center
Knoxville Tennessee 37920
Updated

A clinical trial to evaluate treatments using LiRIS 400 mg and LiRIS Placebo for patients with Interstitial Cystitis

Texas

MediciNova Investigational Site
Corsicana Texas 75110

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

MediciNova Investigational Site
Fort Worth Texas 76104

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Utah

MediciNova Investigational Site
Ogden Utah 84403

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Washington

Integrity Medical Research
Mountlake Terrace Washington 98043
Updated

A clinical trial to evaluate treatments using LiRIS 400 mg and LiRIS Placebo for patients with Interstitial Cystitis

MediciNova Investigational Site
Mountlake Terrace Washington 98043

Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

Canada

Exdeo Clinical Research Inc.
Abbotsford British Columbia V2S 3N6
Updated

A clinical trial to evaluate treatments using LiRIS 400 mg and LiRIS Placebo for patients with Interstitial Cystitis

AQX/CMX site
Barrie Ontario

A Phase 2 clinical study for patients with Interstitial Cystitis or Bladder Pain Syndrome

AQX/CMX site
Brampton Ontario

A Phase 2 clinical study for patients with Interstitial Cystitis or Bladder Pain Syndrome

AQX/CMX site
Brantford Ontario

A Phase 2 clinical study for patients with Interstitial Cystitis or Bladder Pain Syndrome

AQX/CMX site
Burlington Ontario

A Phase 2 clinical study for patients with Interstitial Cystitis or Bladder Pain Syndrome

View More »

AQX/CMX site
Granby Quebec

A Phase 2 clinical study for patients with Interstitial Cystitis or Bladder Pain Syndrome

AQX/CMX site
Kelowna British Columbia

A Phase 2 clinical study for patients with Interstitial Cystitis or Bladder Pain Syndrome

First 1 2 Last